Showing results (21-30 of 52) with videos related to
Sort By:
Pageof 6
Journal of Clinical Pharmacology|June 1, 1994
Etiologic significance of arginine vasopressin in motion sicknessB S Cheung, R L Kohl, K E Money, et al.The Journal of Cell Biology|July 1, 1976
Teleost chloride cell. II. Autoradiographic localization of gill Na,K-ATPase in killifish Fundulus heteroclitus adapted to low and high salinity environmentsK J Karnaky, L B Kinter, W B Kinter, et al.Journal of Clinical Pharmacology|February 1, 1992
Investigation of anti-motion sickness drugs in the squirrel monkeyB S Cheung, K E Money, R L Kohl, et al.Journal of Applied Physiology (Bethesda, Md. : 1985)|January 1, 1988
Nasal delivery of a vasopressin antagonist in dogsG G Liversidge, C G Wilson, W L Sternson, et al.The Journal of Pharmacology and Experimental Therapeutics|June 1, 1987
Vasopressin antagonism in the squirrel monkey (Saimiri sciureus)L B Kinter, S Churchill, F L Stassen, et al.Chirality|January 11, 1990
Characterization of the hemodynamic activities of fenoldopam and its enantiomers in the dogL B Kinter, E Horner, W A Mann, et al.Journal of Cardiovascular Pharmacology|January 1, 1986
Discovery and therapeutic utility of vasopressin antagonists in ratsL B Kinter, G Dytko, D Ashton, et al.Circulatory Shock|October 1, 1989
Effect of a selective V1 vasopressin receptor antagonist on the sequelae of endotoxemia in the conscious ratJ W Egan, M Jugus, L B Kinter, et al.Eicosanoids|January 1, 1989
Concentration-dependent, stereoselective inhibition of the endotoxin-induced hemoconcentration in conscious rats with the peptidoleukotriene receptor antagonist SK & F 104353E F Smith, L B Kinter, M Jugus, et al.The American Journal of Physiology|March 1, 1990
Physiological regulation of the renal vasopressin receptor-effector pathway in dogsL B Kinter, N Caldwell, S Caltabiano, et al.Pageof 6